The association between sleep duration and cancer-specific mortality: a systematic review and meta-analysis

Stone, Christopher D.; Haig, Tiffany R.; Fiest, Kirsten M.; McNeil, Jessica; Brenner, Darren R.; Friedenreich, Christine M.

doi:10.1007/s10552-019-01156-4

Cited by 65 publications

(50 citation statements)

References 71 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Long sleep duration was independently associated with colorectal and gastric cancer in our study. Long sleep duration has been associated with higher all-cause and cancer-specific mortality in several meta-analyses including a large number of observational studies 4 , 23 , 24 . To date, only a few studies have examined the association of sleep duration with cancer risk for tumors other than breast cancer 11 , 14 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

Papantoniou

Castaño‐Vinyals

Espinosa

et al. 2021

Sci Rep

View full text Add to dashboard Cite

Sleep duration is a novel and potentially modifiable risk factor for cancer. We evaluated the association of self-reported sleep duration and daytime napping with odds of colorectal and gastric cancer. We included 2008 incident colorectal cancer cases, 542 gastric cancer cases and 3622 frequency-matched population controls, recruited in the MCC-Spain case–control study (2008–2013). Sleep information, socio-demographic and lifestyle characteristics were obtained through personal interviews. Multivariable adjusted logistic regression models were used to estimate odds ratios (OR) with 95% confidence intervals (CI) for cancer, across categories of sleep duration (≤ 5, 6, 7, 8, ≥ 9 hours/day), daytime napping frequency (naps/week) and duration (minutes/nap). Compared to 7 hours of sleep, long sleep was associated with increased odds of colorectal (OR≥9 hours: 1.59; 95%CI 1.30–1.94) and gastric cancer (OR≥9 hours: 1.95; 1.37–2.76); short sleep was associated with increased odds of gastric cancer (OR≤5 hours: 1.32; 0.93–1.88). Frequent and long daytime naps increased the odds of colorectal (OR6–7 naps/week, ≥30 min: 1.32; 1.14–1.54) and gastric cancer (OR6–7 naps/week, ≥30 min: 1.56; 1.21–2.02). Effects of short sleep and frequent long naps were stronger among participants with night shift-work history. Sleep and circadian disruption may jointly play a role in the etiology of colorectal and gastric cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Sleep duration has been suggested as a novel and potentially modifiable risk factor for chronic disease incidence and mortality 4 – 6 . Specifically, short and long sleep duration have been associated with a higher risk for cardiovascular disease 7 , type II diabetes 8 , 9 , obesity 9 , 10 and cancer 11 – 13 .…”

Section: Introductionmentioning

confidence: 99%

Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

Papantoniou

Castaño‐Vinyals

Espinosa

et al. 2021

Sci Rep

View full text Add to dashboard Cite

show abstract

“…According to the consensus of the National Sleep Foundation in the United States, the recommended level of sleep duration for young and older adults is 7-9 and 7-8 hours, respectively [1]. Inappropriate sleep duration, as reported by numerous studies, was associated with various adverse health outcomes including obesity, type 2 diabetes, cardiovascular disease, cancer, cognitive decline as well as total and cause-specific mortality [2][3][4][5][6]. A U-shaped pattern of the effects has been observed, that is long and short sleep duration increased the risk of all-cause mortality in general population [7,8].…”

Section: Introductionmentioning

confidence: 99%

Sleep duration and all-cause mortality in the elderly in China: a population-based cohort study

et al. 2020

View full text Add to dashboard Cite

Background Although a U-shaped association between sleep duration and all-cause mortality has been found in general population, its association in the elderly adults, especially in the oldest-old, is rarely explored. Methods In present cohort study, we prospectively explore the association between sleep duration and all-cause mortality among 15,092 participants enrolled in the Chinese Longitudinal Healthy Longevity Survey (CLHLS) from 2005 to 2019. Sleep duration and death information was collected by using structured questionnaires. Cox regression model with sleep duration as a time-varying exposure was performed to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs). The dose-response association between them was explored via a restricted cubic spline function. Results During an average follow-up of 4.51 (standard deviation, SD: 3.62) years, 10,768 participants died during the follow-up period. The mean (SD) age of the participants was 89.26 (11.56) years old. Compared to individuals with moderate sleep duration (7–8 hours), individuals with long sleep duration (> 8 hours) had a significantly higher risk of all-cause mortality (HR: 1.13, 95%CI: 1.09–1.18), but not among individuals with short sleep duration (≤ 6 hours) (HR: 1.02, 95%CI: 0.96–1.09). Similar results were observed in subgroup analyses based on age and gender. In the dose-response analysis, a J-shaped association was observed. Conclusions Sleep duration was associated with all-cause mortality in a J-shaped pattern in the elderly population in China.

show abstract

“…Sleep disturbance in breast cancer patients was associated with higher all-cause mortality risk in a 30-year follow-up study [11]. In addition, improvement with respect to sleep disturbance was reported to be associated with survival in cancer patients [12]. In particular, decreased nocturnal sleep duration was reported to have a negative impact on cancer survival [13].…”

Section: Introductionmentioning

confidence: 99%

An Exploratory Study on the Effects of Forest Therapy on Sleep Quality in Patients with Gastrointestinal Tract Cancers

Kim

Lee

et al. 2019

IJERPH

View full text Add to dashboard Cite

The improvement of sleep quality in patients with cancer has a positive therapeutic effect on them. However, there are no specific treatment guidelines for treating sleep disturbance in cancer patients. We investigated the effect of forest therapy on the quality of sleep in patients with cancer. This study was conducted on nine patients (one male, eight female; mean age, 53.6 ± 5.8 years) with gastrointestinal tract cancer. All patients participated in forest therapy for six days. They underwent polysomnography (PSG) and answered questionnaires on sleep apnea (STOP BANG), subjective sleep quality (Pittsburgh Sleep Quality Index, PSQI), sleepiness (Stanford and Epworth Sleepiness Scales), and anxiety and depression (Hospital Anxiety and Depression Scale) to evaluate the quality of sleep before and after forest therapy. Sleep efficiency from the PSG results was shown to have increased from 79.6 ± 6.8% before forest therapy to 88.8 ± 4.9% after forest therapy (p = 0.027) in those patients, and total sleep time was also increased, from 367.2 ± 33.4 min to 398 ± 33.8 min (p = 0.020). There was no significant difference in the STOP BANG score, PSQI scores, daytime sleepiness based on the results of the Stanford and Epworth Sleepiness Scales, and depression and anxiety scores. Based on the results of this study, we suggest that forest therapy may be helpful in improving sleep quality in patients with gastrointestinal cancers.

show abstract

The association between sleep duration and cancer-specific mortality: a systematic review and meta-analysis

Cited by 65 publications

References 71 publications

Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

Sleep duration and all-cause mortality in the elderly in China: a population-based cohort study

An Exploratory Study on the Effects of Forest Therapy on Sleep Quality in Patients with Gastrointestinal Tract Cancers

Contact Info

Product

Resources

About